Definitive Contract 75N93019C00024
Award Date
8/14/19
Potential Completion Date
8/18/20
Potential Value
$200K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Luminostics Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95138, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health's National Heart, Lung and Blood Institute awarded Lumiradx, Inc. a $243,000 firm fixed-price purchase order to finalize development of its SARS-CoV-2 and influenza A/B test. As the prime contractor, Lumiradx will deliver its LumiraDx Platform test to the NIH for use in detecting the viruses that cause COVID-19 and seasonal flu. No subcontractors or set-aside designations were identified. This purchase order supports the NIH's ongoing efforts to expand...
This contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Luminostics Inc., a for-profit medical technology company. The $39,067,500.00 Firm Fixed Price contract is for the RADX-TECH program to develop and deliver a smartphone-based point-of-care test for rapid SARS-CoV-2 antigen detection from nasal swabs. This contract was not set aside for any particular business type. Luminostics has received prior federal contract and grant awards related to...
This federal contract award, valued at $67,690.00, was issued by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract was for the procurement of 15 units of the RPP NXTAG (RUO) 96 Tests, a multiplex assay that can simultaneously detect 22 respiratory pathogens, to be used in NIAID's ongoing...
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a firm fixed-price purchase order contract worth $5,389,813.00 to Luminex Corporation. The contract is for the integration of the SARS-CoV-2 virus with the NxTAG Respiratory Pathogen Panel and the submission of a 510(k) application to the U.S. Food and Drug Administration. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions,...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $224,751 firm-fixed-price contract to Glucosentient Inc., a small business, for the development of a "TELE-MONITORING FOR INFECTIOUS DISEASES: A REMOTE SYSTEM FOR ASSESSING PATIENT PARAMETERS AND SPECIMEN ANALYSIS." The contract, which has an ultimate completion date of August 29, 2017, was set aside for small businesses. Glucosentient, a...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Luna Innovations Incorporated, a leading provider of advanced fiber optic sensing and measurement systems. The contract, valued at $224,997, is for the development of "INNOVATIVE ORAL FORMULATIONS FOR ANTI-TB DRUGS." This Firm Fixed Price contract has an ultimate completion date of August 25, 2017. Luna Innovations, a for-profit manufacturer, is...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $300,000 Firm Fixed Price Definitive Contract to L2 Diagnostics LLC, a small business, for the NOVEL DIAGNOSTIC BIOMARKERS DISCOVERY AND VALIDATION FOR MALARIA SBIR PHASE I effort. This Small Business Innovation Research (SBIR) Phase I contract has a performance period ending on November 30, 2025 and is set aside for total small business participation. L2 Diagnostics LLC is a for-profit limited...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, has awarded a Small Business Innovation Research (SBIR) Phase I Definitive Contract with a ceiling value of $299,326.00 to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract requires Lynntech to design and develop a novel "3IN1" approach to efficiently collect samples (blood, sputum, urine) in field locations to support surveillance...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Program Phase I action contract to Visby Medical, Inc., a for-profit medical diagnostics manufacturer. The $140,000.00 firm-fixed-price contract, which was set aside for small businesses, is for the development of a rapid, accurate point-of-care diagnostic test under SBIR Topic 075. Visby Medical has received...
This is a $300,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Luna Labs USA LLC, a small business manufacturer based in Charlottesville, Virginia. The contract is for the AMPFLI: Rapid Nucleic Acid Test for HIV-1 under the Small Business Innovation Research (SBIR) Program Phase I. The contract has a completion date of April 14, 2025. Luna Labs USA LLC, a division of Luna Innovations Incorporated, has...